- Home
- BMR vs IKNA Comparison
BMR vs IKNA Comparison
Compare BMR & IKNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMR
- IKNA
- Stock Information
- Founded
- BMR 2009
- IKNA 2016
- Country
- BMR Israel
- IKNA United States
- Employees
- BMR N/A
- IKNA N/A
- Industry
- BMR Computer Software: Prepackaged Software
- IKNA Biotechnology: Pharmaceutical Preparations
- Sector
- BMR Technology
- IKNA Health Care
- Exchange
- BMR Nasdaq
- IKNA Nasdaq
- Market Cap
- BMR 59.3M
- IKNA 52.1M
- IPO Year
- BMR 2023
- IKNA 2021
- Fundamental
- Price
- BMR $2.89
- IKNA $1.19
- Analyst Decision
- BMR
- IKNA Buy
- Analyst Count
- BMR 0
- IKNA 2
- Target Price
- BMR N/A
- IKNA $3.00
- AVG Volume (30 Days)
- BMR 76.0K
- IKNA 109.0K
- Earning Date
- BMR 06-10-2025
- IKNA 05-08-2025
- Dividend Yield
- BMR N/A
- IKNA N/A
- EPS Growth
- BMR N/A
- IKNA N/A
- EPS
- BMR N/A
- IKNA N/A
- Revenue
- BMR $3,064,000.00
- IKNA N/A
- Revenue This Year
- BMR N/A
- IKNA N/A
- Revenue Next Year
- BMR N/A
- IKNA N/A
- P/E Ratio
- BMR N/A
- IKNA N/A
- Revenue Growth
- BMR 5.33
- IKNA N/A
- 52 Week Low
- BMR $1.86
- IKNA $0.97
- 52 Week High
- BMR $6.71
- IKNA $1.94
- Technical
- Relative Strength Index (RSI)
- BMR 58.49
- IKNA 53.94
- Support Level
- BMR $2.54
- IKNA $1.10
- Resistance Level
- BMR $2.80
- IKNA $1.20
- Average True Range (ATR)
- BMR 0.18
- IKNA 0.08
- MACD
- BMR 0.00
- IKNA 0.01
- Stochastic Oscillator
- BMR 67.44
- IKNA 74.26
About BMR Beamr Imaging Ltd.
Beamr Imaging Ltd is a video technology and image science software company. It is an innovator of video encoding, transcoding, and optimization solutions that enable high quality, performance, and unmatched bitrate efficiency for video and images. The company is conducted through one operating segment, the optimization technology for video and photo compression. The company operates in Israel, the United States, and the rest of the world, it derives a majority of its revenue from the United States.
About IKNA Ikena Oncology Inc.
Ikena Oncology Inc is a targeted oncology company developing precision therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance in the Hippo and RAS onco-signaling network. Its targeted oncology product candidate, IK-930, is an oral small-molecule inhibitor of the transcriptional enhanced associate domain, or TEAD, a transcription factor in the Hippo signaling pathway, a known oncogenic pathway that also drives resistance to multiple targeted and chemotherapies. Its other product candidates are IK-175 and IK-595.